WADA - Updates to documents relating to the narcotic tramadol that is on the 2024 Prohibited List

22 Nov 2023

Updates to documents relating to the narcotic tramadol that is on the 2024 Prohibited List / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023

WADA has published the following updates related to the narcotic tramadol that has been added to the 2024 Prohibited List; and, will be prohibited in competition, effective 1 January 2024: 

1.) An update to the 2024 Summary of Major Modifications and Explanatory Notes, which relates to tramadol. 

2.) A Technical Letter dealing with the Minimum Reporting Level (MRL) for Tramadol

3.) Tramadol-related Factsheets

SAIDS 2021_23 SAIDS vs Annah Watkinson

21 Nov 2023

In January 2022 the South African Institute for Drugfree Sport (SAIDS) reported an anti-doping rule violation against the triathlon Athlete Annah Watkinson after her sample tested positive for the prohibited substance Mestanolone in a low concentration.

Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the SAIDS Anti-Doping Tribunal.

SAIDS contended that that Athlete failed to prove with corroborating evidence that the violation was not intentional and how the subtance had entered her system.

The Athlete attempted to identify the source of the prohibited substance with testst, experts and legal representative. Also she attempted to demonstrate that the violation was not intentional and that she had not acted recklessly.

The Athlete presented three possible sources of the prohibited substance:

  • Contamination or cross contamination of a peanut butter smoothie;
  • The transfer of the prohibited substance to her by her boyfriend through kissing;
  • The use of a steroid cream by someone who shared the swimming pool with her.

Regarding the possible sources the Panel assessed and adressed in detail the evidence raised by the Athlete. However, the Panel concludes that the hypothesis is not probable and the theories unlikely.

Furthermore the Panel did not accept that as an experienced athlete in the Doping Process she only had mentioned on the Doping Control Form the supplements she had use on the day of the test and not the preceeding 7 days.

Despite the Athlete tried to demonstrate with evidence that she not had been dishonest or reckless the Panel concludes that she failed to establish that the violation was not intentional.

Therefore the Panel decides on 21 November 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 11 January 2022.

ADAPI 2023_11 Kashish Malik vs INADA - Appeal

21 Nov 2023

On 8 March 2023 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 2 year period of ineligibility on the taekwondo Athlete Kashish Malik after he tested positive for the prohibited substance Furosemide.

Hereafter the Athlete appealed the ADDPI decision with the Anti-Doping Appeal Panel of India (ADDPI). The Athlete requested the Appeal Panel to set aside the Appealed Decision and for a reduced sanction.

The Athlete asserted that in first instance the ADDPI had not considered evidence demonstrating that she had a medical prescription as treatment for her diagnosed infection. By contrast the India National Anti-Doping Agency (INADA) contended that the Athlete had failed to apply for a TUE, nor mentioned her medication on the Doping Control Form.

The Appeal Panel determines that the Athlete, as an experienced professional, failed to produce evidence of purchase of her medication, including the prescribed medication Lasix. Further she failed to check her medication and neither informed her sports doctor about her condition and prescribed medication.

The Appeal Panel concludes that the Athlete had committed an anti-doping rule violation and deems that she failed to demonstrate that there are grounds for No Significant Fault or Negligence.

Therefore the ADDPI Panel decides on 21 November 2023 to uphold the Appealed Decision and the imposed 2 year period of ineligibility, starting on the date of the ADDPI Decision.

Annual banned-substance review: analytical approaches in human sports drug testing - [2022-2023]

20 Nov 2023

Annual banned-substance review: analytical approaches in human sports drug testing / Mario Thevis, Tiia Kuuranne, Hans Geyer

  • Drug Testing and Analysis 16 (2024) 1 (January), p. 5-29
  • PMID: 37985429
  • DOI: 10.1002/dta.3602


Contents:

  • Introduction
  • Anabolic Agent
    • Anabolic-androgenic steroids (AASs)
    • Initial testing procedures (ITPs)—
      Comprehensive screening and metabolism studies
    • Other anabolic agents
    • Steroid profiling in urine and blood
    • Confirmatory testing procedures—Isotope
      ratio mass spectrometry (IRMS)
  • Peptide Hormones, Growth Factors, Related Substances, and Mimetics
    • EPO-receptor agonists (ERAs) and hypoxiainducible
      factor (HIF) activating agents
    • Peptide hormones and their releasing factors,
      growth factors, and growth factor modulators
  • Β2-Agonists, Hormone, And Metabolic Modulators

    • β2-Agonists
    • Hormone and metabolic modulators
  • Diuretics And Masking Agents,
  • Stimulants And Narcotics
  • Glucocorticoids, Cannabinoids, And Beta-Blockers
  • Manipulation Of Blood And Blood Components
  • Gene Doping
  • Conclusion And Perspectives



Abstract

In this 16th edition of the annual banned-substance review on analytical approaches in human sports drug testing, literature on recent developments in this particular section of global anti-doping efforts that was published between October 2022 and September 2023 is summarized and discussed. Most recent additions to the continuously growing portfolio of doping control analytical approaches and investigations into analytical challenges in the context of adverse analytical findings are presented, taking into account existing as well as emerging challenges in anti-doping, with specific focus on substances and methods of doping recognized in the World Anti-Doping Agency's 2023 Prohibited List. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls, appreciating the exigence and core mission of anti-doping and, equally, the conflict arising from the opposingly trending extent of the athlete's exposome and the sensitivity of instruments nowadays commonly available in anti-doping laboratories.

ADAPI 2023_22 Radhika Prakash Awati vs INADA - Appeal

18 Nov 2023

In June 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the fencer Radhika Prakash Awati after she tested positive for the prohibited substance Methylprednisolone.

Following notification the Athlete's application for a retrospective TUE was rejected in May 2023 by the TUE Committee. Also her TUE appeal was dismissed in July 2023.

Consequently on 17 August 2023 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 15 month period of ineligibility on the Athlete.

Hereafter the Athlete and INADA appealed the ADDPI decision with the Anti-Doping Appeal Panel of India (ADAPI). Both parties requested the Appeal Panel to modify the Appealed Decision regarding the length of the sanction.

The Athlete denied the intentional use of the substance and argued that she acted with No Significant Fault or Negligence. She asserted that she was unaware that her prescribed medication contained a prohibited substance which she mentioned on the Doping Control Form.

INADA contended that there are no grounds for a reduced sanction and requested the Appeal Panel for a 2 year sanctionb. Without corroborating evidence the Athlete was not credible about the medical treatment she underwent in a hospital.

The Appeal Panel assessed the Athlete's conduct in this case and agrees that she failed to demonstrate with corroborating evidence that she acted with No Significant Fault or Negligence. She filed a dubious medical prescription while there was no hospital records, nor evidence of the purchase of the medication.

Therefore the ADAPI Panel decides on 18 November 2023 to set aside the Appealed Decision and to impose a 2 year period of ineligibility on the Athlete, starting on 17 August 2023.

CCES Annual Report 2022-2023 (Canada)

17 Nov 2023

Annual report 2022-2023 / Canadian Centre for Ethics in Sport (CCES). - Ottawa : CCES, 2023

World Athletics 2023 WA vs Janat Chemusto

17 Nov 2023

In July 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Ugandees Athlete Janat Chemusto after her sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone). Following notification a provisional suspension was ordered and the Athlete filed a statement in her defence.

The Athlete asserted with medical documents that the prescribed medication she had used for her condition probably were the source of the prohibited substance. Yet, the AIU concluded that her medication could not explain the presence of Nandrolone in her sample.

The AIU determined that the Athlete failed to demonstrate that the violation was not intentional. As a result the AIU offered the Athlete a 1 year reduction when she timely returned a signed Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form.

Following reminders by the AIU in October 2023 the Athlete ultimately returned the Admission Form 3 days beyond the set deadline. Thereupon she failed to demonstrate with evidence that her signed Admission Form indeed had been completed on or before the date of the deadline.

The AIU establishes that the Athlete failed to respond and to  confirm that she disputed the consequences of the violation in her case by the deadlines specified by the AIU. Accordingly the Athlete is deemed to have waived her right to a hearing and accepted the consequences.

Therefore the AIU decides on 17 November 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 13 July 2023.

World Athletics 2022 WA vs Christopher Taylor

17 Nov 2023

In January 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping rule violation against the Jamaican Athlete Christopher Taylor for his failure to submit to sample collection out-of-competition on 16 November 2022. 

Following notification and a Notice of Allegation in May 2023 the Athlete gave a timely admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by the AIU.

Thereupon the Athlete the AIU and WADA entered into a Case Resolution Agreement for the imposition of a reduced sanction due to exceptional circumstances.

Therefore on 17 November 2023 the Athlete accepts a 30 month period of ineligibility, starting on the date of the violation, i.e. on 16 November 2022.

UKAD 2023 UKAD vs Krzysztof Glowacki

13 Nov 2023

In April 2023 the United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the Polish boxer Krzysztof Glowacki after his sample tested positive for the prohibited substance Boldenone. Following notification a provisional suspension was ordered and the Athlete was heard for the National Anti-Doping Panel.

The Athlete denied the intentional use of the substance and stated that prior he had received medical treatment from a doctor in Warsaw for the serious injury to his hand. Yet the Athlete was hampered to provide timely sufficient evidence from a clinic accompanied by an official translation before he attended the hearing.

The Panel determines that the Athlete's medical treatment with (the banned substance) Betamethasone for his injury could not explain the presence of Boldenone in his system. Ultimately the Panel concludes that the Athlete failed to establish with corroborating evidence that the violation was not intentional and that there are no exceptional circumstances.

Therefore the Panel decides on 13 November 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 6 April 2023.

UKAD 2023 UKAD vs Tobias Richardson

13 Nov 2023

In August 2023 the United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the rugby player Tobias Richardson after his sample tested positive for the prohibited substance Cocaine.

Following notification the Athlete admitted the violation, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD.

The Athlete acknowledged that on a Friday with friends he recreationally had used Cocaine out-of-competition and thereupon on Sunday had a match and sample collection. Besides consuming pints of beer on Friday night he had used a total of one gram of Cocaine.

UKAD accepts that the Athlete had used Cocaine out-of-competition in a context unrelated to sport performance that permits the imposition of a reduced sanction.

Therefore UKAD decides on 13 November 2023 to impose a 3 month period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 17 August 2023.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin